Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Kasycas
    Member
    • Sep 2009
    • 22

    #1

    MIRA output for Illumina mapping giving 100% coverage!

    Hi all,

    I've been using MIRA as I have both Illumina and 454 reads that I wanted to do mapping/assembly as well as semi-hybrid and hybrid assembly. However, when I use MIRA on the Illumina data alone for mapping with

    "mira --project=0800 --job=mapping,genome,normal,solexa --fastq -SB:bft=gbf >&0800_Illumina_log_assembly.txt"

    I get 1 contig of length 4,798,671 which is pretty much 100% coverage of the genome! I've used bwa and bowtie as well which give me a more realistic ~68-69% coverage. Can anyone tell me why/how MIRA is doing this? I've played around with the setting and read the documentation but I'm at a loss!

    Thanks,

    Kasycas
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    I'd ask on the MIRA mailing list, but Bastien also posts here.

    My guess is different rules/settings for mismatch thresholds, but also MIRA isn't really doing a mapping but a guided assembly (it will extend the reference sequence(s) if it can).
    Last edited by maubp; 09-10-2010, 03:47 AM. Reason: typo

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Working...